Five-Year Prostate-Specific Membrane Antigen Positron Emission Tomography-Based Outcomes of Spot-Scanning Proton Radiation Therapy for Localized Prostate Cancer: A Single Institution Experience
SSPT provides high local control rates and excellent oncologic outcomes across different fractionation schedules with low long-term AE rates.
Authors
- Brady Laughlin
- Molly M. Voss
- Nathan Y. Yu (ORCID: https://orcid.org/0000-0003-4059-650X)
- T.A. DeWees (ORCID: https://orcid.org/0000-0003-3897-3011)
- Steven E. Schild (ORCID: https://orcid.org/0000-0002-2850-4126)
- T.B. Daniels
- Sameer R. Keole
- Carlos Vargas (ORCID: https://orcid.org/0000-0002-1614-3562)
- William W. Wong (ORCID: https://orcid.org/0000-0002-7629-5859)
- Sarah E. James
- Jean-Claude M. Rwigema
- Will Sperduto
- Diego A.S. Toesca
Institutions
- Quantitative BioSciences (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic Hospital (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Advances in Radiation Oncology
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1016/j.adro.2024.101639
- Primary Topic
- Radiation Therapy and Dosimetry
- Type
- article
- Field-Weighted Citation Impact
- 0.00